Skip to main content

Baseline Urinary Glucose Tetrasaccharide Concentrations in Patients with Infantile- and Late-Onset Pompe Disease Identified by Newborn Screening.

Publication ,  Chapter
Chien, Y-H; Goldstein, JL; Hwu, W-L; Smith, PB; Lee, N-C; Chiang, S-C; Tolun, AA; Zhang, H; Vaisnins, AE; Millington, DS; Kishnani, PS; Young, SP
2015

PURPOSE: The urinary glucose tetrasaccharide, Glcα1-6Glcα1-4Glcα1-4Glc (Glc4), is a biomarker of glycogen accumulation and tissue damage and is elevated in patients with Pompe disease. We report baseline urinary Glc4 concentrations for patients with classic infantile-onset or late-onset Pompe disease, and those with a pseudodeficiency of acid alpha-glucosidase (GAA), identified through newborn screening (NBS) in Taiwan. METHODS: Infants identified through NBS with (1) classic infantile-onset Pompe disease (NBS-IOPD) (n = 7) defined as patients with evidence for hypertrophic cardiomyopathy by EKG, X-ray, and echocardiogram, (2) a late-onset phenotype (NBS-LOPD) (n = 13) defined as patients without evidence for cardiomyopathy, (3) a GAA pseudodeficiency (n = 58), and (4) one patient with LOPD diagnosed in infancy due to family history were consented to the study. Four infants diagnosed after the onset of clinical symptoms (CLIN-IOPD) were included for comparison. Glc4 concentrations in dried urine samples on filter paper were determined using tandem mass spectrometry. RESULTS: Baseline Glc4 concentrations were at or above the 90th centile of the age-matched reference range for the NBS-IOPD cohort. The median Glc4 level for this group was lower than that of the CLIN-IOPD group, although not at the level of significance (p = 0.07), but was significantly higher than that of the NBS-LOPD group (p < 0.05). Baseline Glc4 was not elevated for the NBS-LOPD and GAA pseudodeficiency cohorts and remained low for late-onset patients that did not require treatment before the age of three years. CONCLUSION: Baseline urinary Glc4 is elevated in neonates with infantile-onset Pompe disease identified through NBS.

Duke Scholars

DOI

Publication Date

2015

Volume

19

Start / End Page

67 / 73

Related Subject Headings

  • 3202 Clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Chien, Y.-H., Goldstein, J. L., Hwu, W.-L., Smith, P. B., Lee, N.-C., Chiang, S.-C., … Young, S. P. (2015). Baseline Urinary Glucose Tetrasaccharide Concentrations in Patients with Infantile- and Late-Onset Pompe Disease Identified by Newborn Screening. (Vol. 19, pp. 67–73). https://doi.org/10.1007/8904_2014_366
Chien, Yin-Hsiu, Jennifer L. Goldstein, Wuh-Liang Hwu, P Brian Smith, Ni-Chung Lee, Shu-Chuan Chiang, Adviye A. Tolun, et al. “Baseline Urinary Glucose Tetrasaccharide Concentrations in Patients with Infantile- and Late-Onset Pompe Disease Identified by Newborn Screening.,” 19:67–73, 2015. https://doi.org/10.1007/8904_2014_366.
Chien Y-H, Goldstein JL, Hwu W-L, Smith PB, Lee N-C, Chiang S-C, Tolun AA, Zhang H, Vaisnins AE, Millington DS, Kishnani PS, Young SP. Baseline Urinary Glucose Tetrasaccharide Concentrations in Patients with Infantile- and Late-Onset Pompe Disease Identified by Newborn Screening. 2015. p. 67–73.

DOI

Publication Date

2015

Volume

19

Start / End Page

67 / 73

Related Subject Headings

  • 3202 Clinical sciences